... correct violations of the Act in your facility. Your response must address comprehensively each of the violations and specific corrective actions to preclude recurrence. Include in your response steps to correct the violative products in the market... FDA's Generic Drug Approval Process: Hearings Before the Subcommittee on ... - Page 74 by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations - 1989 Full view -
|